NCT06484426 - Goal Attainment Scaling (GAS) Sub-Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions

Alzheimer's Disease in Down Syndrome

Trial Locations (5)

Kennedy Krieger Institute, Baltimore

Advocate Health, Park Ridge

University of California, San Diego, San Diego

Massachusetts General Hospital, Boston

Case Western Reserve University School of Medicine, Cleveland